Archive

EAHP 2012 Report – The EAHP Survey 2010 Preview

Written by Lorraine Carolan | 3 Aug 2012

by Zara Qadir – Five years of evolution in Hospital Pharmacy. The 40th EAHP meeting provided an opportunity for Tajda Miharija-Gala and Juraj Sykora, Directors of Professional Development,… read more.

EAHP 2012 Report – Compassionate use and off-label medicines

Written by Lorraine Carolan | 3 Aug 2012

by Zara Qadir reporting on the presentation by Yechiel Hekster (pictured), Professor of Clinical Pharmacy, and a member of The Netherlands Medicines Evaluation Board.

EAHP 2012 Report – Interview with Dr Chantal Bélorgey

Written by Lorraine Carolan | 3 Aug 2012

Zara Qadir interviews Dr Chantal Bélorgey (pictured), Head of Clinical Trial Development at the French national competent authority, Affsaps (Agence française de sécurité sanitaire des produits).

New skin cancer drug cited as therapeutic breakthrough

Written by Bruce Sylvester | 31 Jul 2012

by Bruce Sylvester taken from the New England Journal of Medicine (NEJM) Vismodegib (Erivedge), a new skin cancer drug for advanced basal cell carcinoma, was called “the greatest… read more.

Opioids double risk of death from any cause

Written by Bruce Sylvester | 31 Jul 2012

by Bruce Sylvester – taken from the British Medical Journal (BMJ) Long-term opium use almost doubles the risk of death from many causes, particularly circulatory diseases, respiratory conditions,… read more.

ASCO 2012 Report – Abiraterone added to pre-surgical regimen helps eliminate prostate tumor in some men with high-risk prostate cancer

Written by Bruce Sylvester | 31 Jul 2012

by Bruce Sylvester – In a randomized Phase II study presented at ASCO, investigators reported that 6 months of treatment with the targeted drug abiraterone (Zytiga) when added… read more.

ASCO 2012 Report – Olanzapine appears to control breakthrough chemotherapy-induced nausea and vomiting

Written by Bruce Sylvester | 31 Jul 2012

by Bruce Sylvester – Investigators from a Phase III trial reported at ASCO that chemotherapy-induced nausea and vomiting (CINV) which is unresponsive to conventional treatments reponds to olanzapine… read more.

ASCO 2012 Report – Combination targeted therapy shows efficacy and fewer toxicities in advanced melanoma treatment

Written by Bruce Sylvester | 31 Jul 2012

by Bruce Sylvester – Results from an expanded Phase IB trial presented at ASCO suggest that combination therapy with two investigational and targeted drugs, BRAF inhibitor dabrafenib and… read more.

ASCO 2012 Report – Early, highly promising results for Crizotinib (Xalkori) in three aggressive pediatric cancers

Written by Bruce Sylvester | 31 Jul 2012

by Bruce Sylvester – In a phase I study presented at ASCO, researchers reported that crizotinib (Xalkori) stalled tumor growth and, in some cases, eradicated all signs of… read more.

Interdisciplinary care helps breast cancer prognosis

Written by Gary Finnegan | 31 Jul 2012

by Gary Finnegan – World Health Matters (Germany) – An interdisciplinary care model for breast cancer management has grown in popularity in recent years and evidence suggests the… read more.

Duloxetine relieves chemotherapy-related neuropathy

Written by Lorraine Carolan | 31 Jul 2012

The antidepressant duloxetine (Cymbalta ®) can effectively treat chemotherapy-induced neuropathy in some patients , researchers reported on July 3, 2012 at the American Society of Clinical Oncology Annual… read more.